Engenhart-Cabillic Rita, Farhoud Ahmed, Sure Ulrich, Heinze Stefan, Henzel Martin, Mennel Hans-Dieter, Bertalanffy Helmut
Department of Radiotherapy and Radiooncology, Philipps University, Baldingerstrasse, 35033 Marburg, Germany.
Strahlenther Onkol. 2006 Nov;182(11):641-6. doi: 10.1007/s00066-006-1555-3.
Although meningiomas are typically benign, they occasionally behave in an aggressive fashion and carry a less favorable prognosis. The aim of this study was to review the clinical, radiologic and histopathologic features of these aggressive variants as well as the outcome after multimodality therapy.
16 patients with atypical meningiomas (n = 11) and anaplastic meningiomas (n = 5) were treated in the Departments of Neurosurgery and Radiation Oncology at the University Hospital of Philipps University Marburg, Germany, between 1997 and 2003. Tumor grading was based on new WHO criteria. There were eleven men and five women with a mean age of 54 years. The median follow-up period was 34 months.
A total of 24 surgical procedures were performed for these 16 patients. Only seven patients underwent postoperative fractionated stereotactic radiotherapy. Patients with atypical meningioma received radiotherapy only for the recurrent disease. Six patients (37.5%) experienced tumor recurrence after a mean period of 27.2 months in spite of gross total resection. Radiographic findings suggestive of aggressiveness were observed mostly with WHO grade III meningiomas. By comparing the proliferation rate in four cases with atypical meningioma operated twice, the recurrent tumor had a higher proliferation rate than the first tumor in three cases. A special proliferation pattern was noticed in MIB-1 with anaplastic meningiomas. The mean overall survival period was 66.5 months. There was no mortality among patients with atypical meningioma, while four out of five patients with anaplastic meningioma died during follow-up.
Considering the higher rate of recurrence in aggressive meningiomas even after radical surgical excision and the possibility that the recurrent tumor is more aggressive than the original one, surgery should be combined with postoperative fractionated radiotherapy to improve local tumor control. The peculiar focal expression patterns of anaplastic meningioma in MIB-1 might be a marker of such malignant development.
虽然脑膜瘤通常为良性,但它们偶尔会表现出侵袭性,预后较差。本研究的目的是回顾这些侵袭性变体的临床、放射学和组织病理学特征以及多模式治疗后的结果。
1997年至2003年期间,德国马尔堡菲利普斯大学医院神经外科和放射肿瘤学部门对16例非典型脑膜瘤(n = 11)和间变性脑膜瘤(n = 5)患者进行了治疗。肿瘤分级基于世界卫生组织的新标准。11名男性和5名女性,平均年龄54岁。中位随访期为34个月。
这16例患者共进行了24次外科手术。仅7例患者接受了术后分次立体定向放疗。非典型脑膜瘤患者仅对复发性疾病进行放疗。尽管进行了全切除,但6例患者(37.5%)在平均27.2个月后出现肿瘤复发。提示侵袭性的影像学表现主要见于世界卫生组织III级脑膜瘤。通过比较4例接受两次手术的非典型脑膜瘤病例的增殖率,3例复发性肿瘤的增殖率高于首次肿瘤。在间变性脑膜瘤的MIB-1中发现了一种特殊的增殖模式。平均总生存期为66.5个月。非典型脑膜瘤患者无死亡,而5例间变性脑膜瘤患者中有4例在随访期间死亡。
考虑到侵袭性脑膜瘤即使在根治性手术切除后仍有较高的复发率,且复发性肿瘤可能比原发肿瘤更具侵袭性,手术应与术后分次放疗相结合以改善局部肿瘤控制。间变性脑膜瘤在MIB-1中独特的局灶性表达模式可能是这种恶性发展的标志物。